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REPLY
We thank Dr. Basavarajaiah and colleagues for their comments
regarding our study (1) recently published in JACC. We also
appreciate their prior contributions to the left atrial (LA) remod-
eling in adolescent trained athletes (2,3) by establishing an appro-
priate threshold value, which is different from what we found in
adult athletes.
The investigation by Dr. Basavarajaiah and colleagues have
shown that atrial remodeling associated with athletic conditioning
differs in young and adolescent athletes because of their incomplete
body maturation and less strenuous conditioning programs. From
this input, we know that transverse LA dimension rarely exceeds
45 mm in younger athletes (2) but may be 45 mm (and up to 50
mm) in adult trained athletes (1). These cut-off values can be used
in clinical practice to differentiate the physiologic atrial enlarge-
ment associated with intensive athletic conditioning from the
pathologic atrial remodeling associated with cardiomyopathies.
We also thank Dr. Spodick for his insights and wisdom
regarding proper interpretation of the scalar electrocardiogram
(ECG) in relation to LA enlargement. Dr. Spodick underscores
the opportunity in our study to assess the presence of interatrial
block (identified as P-wave duration 120 ms), which may be
associated with LA enlargement and represents a marker of atrial
dysfunction and risk for atrial arrhythmias (such as atrial fibrilla-
tion) (4,5). We do not dispute this suggestion, but we wish to
emphasize that the primary focus of our study in highly trained
athletes was the assessment of LA dimensional changes by echo-
cardiography and the relation to clinical profile and course (includ-
ing development of atrial fibrillation). Our data show that LA
enlargement is not responsible, per se, for proclivity to atrial
arrhythmias, including atrial fibrillation in trained individuals (6).
Dr. Spodick is also correct in suggesting that measurement of
LA volume would be more sensitive than that of transverse LA
dimension, which we have reported in the present study (and also
in previous investigations) (1,7). However, our study design
intentionally incorporated this quantitative measure of transverse
LA size, which is most commonly used in the clinical practice, and
conventionally employed in large epidemiological studies (6,8) so
as to be consistent with customary echocardiographic laboratory
interpretation and the published literature in this area.
Finally, Dr. Abinader’s comments regarding the mechanisms of
LA enlargement in trained athletes are of interest. We agree with
Dr. Abinader that rowing/canoeing and cycling involve both
dynamic and static exercise of large muscle groups, which are
responsible for an increase in both preload and afterload during
prolonged training sessions, with the consequence of combined
volume and pressure overload (9). Therefore, the atrial remodeling
we have reported in the present study (1) and in previous
investigations (7) are likely to be the consequence of this combined
hemodynamic overload, as also suggested by the close relation we
have demonstrated between LA and left ventricular dimensional
changes (1).
*Antonio Pelliccia, MD
Barry J. Maron, MD
*National Institute of Sports Medicine
Department of Medicine
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